Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
New set of forest towns to be built between Oxford and Cambridge
5/11/2025
Bradley shuts down Vinícius and shows Liverpool he can be right-back for future | Nick Ames
5/11/2025
England curriculum should focus less on exams and more on life skills, finds review
5/11/2025
Radiohead play career-spanning set in first concert since 2018
5/11/2025
Reeves considers cut to green levies in effort to reduce cost of energy bills
4/11/2025
Soy, oat, almond, rice : which alternative milk is healthiest ?
4/11/2025